TL;DR: A near-atomic resolution structure of the RdRp protein VP2 in complex with its cofactor protein VP4 and genomic RNA within an aquareovirus capsid is presented, providing insights into the mechanism underlying highly coordinated dsRNA virus transcription and assembly.
Abstract: Most double-stranded RNA (dsRNA) viruses transcribe RNA plus strands within a common innermost capsid shell. This process requires coordinated efforts by RNA-dependent RNA polymerase (RdRp) together with other capsid proteins and genomic RNA. Here we report the near-atomic resolution structure of the RdRp protein VP2 in complex with its cofactor protein VP4 and genomic RNA within an aquareovirus capsid using 200-kV cryoelectron microscopy and symmetry-mismatch reconstruction. The structure of these capsid proteins enabled us to observe the elaborate nonicosahedral structure within the double-layered icosahedral capsid. Our structure shows that the RdRp complex is anchored at the inner surface of the capsid shell and interacts with genomic dsRNA and four of the five asymmetrically arranged N termini of the capsid shell proteins under the fivefold axis, implying roles for these N termini in virus assembly. The binding site of the RNA end at VP2 is different from the RNA cap binding site identified in the crystal structure of orthoreovirus RdRp λ3, although the structures of VP2 and λ3 are almost identical. A loop, which was thought to separate the RNA template and transcript, interacts with an apical domain of the capsid shell protein, suggesting a mechanism for regulating RdRp replication and transcription. A conserved nucleoside triphosphate binding site was localized in our RdRp cofactor protein VP4 structure, and interactions between the VP4 and the genomic RNA were identified.
TL;DR: In this paper, the authors proposed a method to screen for and design compounds that interact with the RNA cap binding pocket and identify compounds that bind to PB2 polypeptide fragments.
Abstract: The present invention relates to soluble fragments of the Influenza virus RNA dependent RNA polymerase subunit PB2 and variants thereof, and crystallized complexes thereof comprising an RNA cap analog. This invention also relates to computational methods using the structural coordinates of said complex to screen for and design compounds that interact with the RNA cap binding pocket. In addition, this invention relates to methods identifying compounds that bind to PB2 polypeptide fragments comprising the RNA cap binding pocket, preferably inhibit the interaction with RNA caps or analogs thereof, by using said PB2 polypeptide fragments, preferably in a high-throughput setting. This invention also relates to compounds and pharmaceutical compositions comprising the identified compounds for the treatment of disease conditions due to viral infections caused by negative-sense single stranded RNA viruses.
TL;DR: In this article, a high resolution structure data by X ray crystallography of an RNA cap-binding pocket of an influenza virus RNA-dependent RNA polymerase subunit PB2 was provided.
Abstract: PROBLEM TO BE SOLVED: To provide a high resolution structure data by X ray crystallography of an RNA cap-binding pocket of an influenza virus RNA-dependent RNA polymerase subunit PB2, an arithmetic and in vitro method of identifying a compound capable of binding to a PB2 RNA-binding pocket to prevent RNA polymerase activity, and a pharmacological composition comprising a compound for therapy of virus infections.SOLUTION: Provided are: a soluble fragment of PB2 and a variant thereof and its crystallized complex comprising an RNA cap analogue; an arithmetic method using a structural coordinate of the complex in order to screen and design a compound interacting with an RNA cap-binding pocket; a method of identifying a compound by using the PB2 polypeptide fragment; and a compound for therapy of disease states due to virus infection caused by a negative sense single-strand RNA virus and a pharmaceutical composition comprising this identified compound.
TL;DR: A detailed structural and biochemical characterization of the guanosine cap-binding pocket of the dengue (DEN) and yellow fever (YF) virus MTase enzymes is performed and a detailed model of how the flavivirus MTase protein binds RNA cap structures is presented.
TL;DR: A high resolution structure of ZIKV NS5 methyltransferase bound to a novel S-adenosylmethionine (SAM) analog in which a 4-fluorophenyl moiety substitutes for the methyl group is presented.
Abstract: The Zika virus (ZIKV) has emerged as a major health hazard. We present here a high resolution structure (1.55 A) of ZIKV NS5 methyltransferase bound to a novel S-adenosylmethionine (SAM) analog in which a 4-fluorophenyl moiety substitutes for the methyl group. We show that the 4-fluorophenyl moiety extends into a portion of the RNA binding tunnel that typically contains the adenosine 2′OH of the RNA-cap moiety. Together, the new SAM analog and the high-resolution crystal structure are a step towards the development of antivirals against ZIKV and other flaviviruses.